Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: BostonView who wrote (7905)	12/2/1998 1:44:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

As one of the anyones, it seems important to get this done in this tax year. Don't forget to read the prospectus, as not only do I drool on my keyboard, but I forget things. The change involves a sale of assets based on accountants fair value. This sale of assets generates a potential tax liability for the capital gain incurred in the sale of assets. Remember patents are assets also. Now, if XOMA in future years is a company producing revenues, from sales, partnerships, license agreements and etc. then it will have more assets and changing domicile becomes less attractive or costly. You can see why a company like General Motors is still domiciled here.